Top

Molecular Neurodegeneration

Published in:

Open Access 01-12-2016 | Research article

Tau mutant A152T, a risk factor for FTD/PSP, induces neuronal dysfunction and reduced lifespan independently of aggregation in a C. elegans Tauopathy model

Authors: Ghulam Jeelani Pir, Bikash Choudhary, Eckhard Mandelkow, Eva-Maria Mandelkow

Published in: Molecular Neurodegeneration | Issue 1/2016

Abstract

Background

A certain number of mutations in the Microtubule-Associated Protein Tau (MAPT) gene have been identified in individuals with high risk to develop neurodegenerative diseases, collectively called tauopathies. The mutation A152TMAPT was recently identified in patients diagnosed with frontotemporal spectrum disorders, including Progressive Supranuclear Palsy (PSP), Frontotemporal Dementia (FTD), Corticobasal Degeneration (CBD), and Alzheimer disease (AD). The A152TMAPT mutation is unusual since it lies within the N-terminal region of Tau protein, far outside the repeat domain that is responsible for physiological Tau-microtubule interactions and pathological Tau aggregation. How A152TMAPT causes neurodegeneration remains elusive.

Results

To understand the pathological consequences of this mutation, here we present a new Caenorhabditis elegans model expressing the mutant A152TMAPT in neurons. While expression of full-length wild-type human tau (Tau^wt, 2N4R) in C. elegans neurons induces a progressive mild uncoordinated locomotion in a dose-dependent manner, mutant tau (Tau^A152T, 2N4R) induces a severe paralysis accompanied by acute neuronal dysfunction. Mutant Tau^A152T worms display morphological changes in neurons reminiscent of neuronal aging and a shortened life-span. Moreover, mutant A152T overexpressing neurons show mislocalization of pre-synaptic proteins as well as distorted mitochondrial distribution and trafficking. Strikingly, mutant tau-transgenic worms do not accumulate insoluble tau aggregates, although soluble oligomeric tau was detected. In addition, the full-length A152T-tau remains in a pathological conformation that accounts for its toxicity. Moreover, the N-terminal region of tau is not toxic per se, despite the fact that it harbours the A152T mutation, but requires the C-terminal region including the repeat domain to move into the neuronal processes in order to execute the pathology.

Conclusion

In summary, we show that the mutant Tau^A152T induces neuronal dysfunction, morphological alterations in neurons akin to aging phenotype and reduced life-span independently of aggregation. This comprehensive description of the pathology due to Tau^A152T opens up multiple possibilities to identify cellular targets involved in the Tau-dependent pathology for a potential therapeutic intervention.

Available only for authorised users

Goedert M, Crowther RA, Spillantini MG. Tau mutations cause frontotemporal dementias. Neuron. 1998;21(5):955–8.PubMedCrossRef

Grundke-Iqbal I, Iqbal K, Tung YC, Quinlan M, Wisniewski HM, Binder LI. Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc Natl Acad Sci U S A. 1986;83(13):4913–7.PubMedPubMedCentralCrossRef

Mandelkow EM, Mandelkow E. Biochemistry and cell biology of tau protein in neurofibrillary degeneration. Cold Spring Harb Perspect Med. 2012;2(7):a006247. doi:10.1101/cshperspect.a006247.PubMedPubMedCentralCrossRef

McKhann GM, Albert MS, Grossman M, Miller B, Dickson D, Trojanowski JQ. Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick’s Disease. Arch Neurol. 2001;58(11):1803–9.PubMedCrossRef

von Bergen M, Barghorn S, Biernat J, Mandelkow EM, Mandelkow E. Tau aggregation is driven by a transition from random coil to beta sheet structure. Biochim Biophys Acta. 2005;1739(2-3):158–66.CrossRef

Coppola G, Chinnathambi S, Lee JJ, Dombroski BA, Baker MC, Soto-Ortolaza AI, et al. Evidence for a role of the rare p.A152T variant in MAPT in increasing the risk for FTD-spectrum and Alzheimer’s diseases. Hum Mol Genet. 2012;21(15):3500–12. doi:10.1093/hmg/dds161.PubMedPubMedCentralCrossRef

Kara E, Ling H, Pittman AM, Shaw K, de Silva R, Simone R, et al. The MAPT p.A152T variant is a risk factor associated with tauopathies with atypical clinical and neuropathological features. Neurobiol Aging. 2012;33(9):2231 e7- e14. doi:10.1016/j.neurobiolaging.2012.04.006.CrossRef

Kovacs GG, Wohrer A, Strobel T, Botond G, Attems J, Budka H. Unclassifiable tauopathy associated with an A152T variation in MAPT exon 7. Clin Neuropathol. 2011;30(1):3–10.PubMedCrossRef

Morris M, Maeda S, Vossel K, Mucke L. The many faces of tau. Neuron. 2011;70(3):410–26. doi:10.1016/j.neuron.2011.04.009.PubMedPubMedCentralCrossRef

10.

Hanger DP, Lau DH, Phillips EC, Bondulich MK, Guo T, Woodward BW, et al. Intracellular and extracellular roles for tau in neurodegenerative disease. J Alzheimers Dis. 2014;40 Suppl 1:S37–45. doi:10.3233/JAD-132054.PubMed

11.

Alexander AG, Marfil V, Li C. Use of Caenorhabditis elegans as a model to study Alzheimer’s disease and other neurodegenerative diseases. Front Genet. 2014;5:279. doi:10.3389/fgene.2014.00279.PubMedPubMedCentralCrossRef

12.

Therrien M, Parker JA. Worming forward: amyotrophic lateral sclerosis toxicity mechanisms and genetic interactions in Caenorhabditis elegans. Front Genet. 2014;5:85. doi:10.3389/fgene.2014.00085.PubMedPubMedCentralCrossRef

13.

Schmidt E, Seifert M, Baumeister R. Caenorhabditis elegans as a model system for Parkinson’s disease. Neurodegener Dis. 2007;4(2-3):199–217. doi:10.1159/000101845.PubMedCrossRef

14.

Shaye DD, Greenwald I. OrthoList: a compendium of C. elegans genes with human orthologs. PLoS One. 2011;6(5):e20085. doi:10.1371/journal.pone.0020085.PubMedPubMedCentralCrossRef

15.

Kraemer BC, Schellenberg GD. SUT-1 enables tau-induced neurotoxicity in C. elegans. Hum Mol Genet. 2007;16(16):1959–71. doi:10.1093/hmg/ddm143.PubMedCrossRef

16.

Guthrie CR, Schellenberg GD, Kraemer BC. SUT-2 potentiates tau-induced neurotoxicity in Caenorhabditis elegans. Hum Mol Genet. 2009;18(10):1825–38. doi:10.1093/hmg/ddp099.PubMedPubMedCentralCrossRef

17.

Fatouros C, Pir GJ, Biernat J, Koushika SP, Mandelkow E, Mandelkow EM, et al. Inhibition of tau aggregation in a novel Caenorhabditis elegans model of tauopathy mitigates proteotoxicity. Hum Mol Genet. 2012;21(16):3587–603. doi:10.1093/hmg/dds190.PubMedCrossRef

18.

Wischik CM, Staff RT, Wischik DJ, Bentham P, Murray AD, Storey JM, et al. Tau aggregation inhibitor therapy: an exploratory phase 2 study in mild or moderate Alzheimer’s disease. J Alzheimers Dis. 2015;44(2):705–20. doi:10.3233/JAD-142874.PubMed

19.

Schuske K, Beg AA, Jorgensen EM. The GABA nervous system in C. elegans. Trends Neurosci. 2004;27(7):407–14. doi:10.1016/j.tins.2004.05.005.PubMedCrossRef

20.

Lundquist EA, Reddien PW, Hartwieg E, Horvitz HR, Bargmann CI. Three C. elegans Rac proteins and several alternative Rac regulators control axon guidance, cell migration and apoptotic cell phagocytosis. Development. 2001;128(22):4475–88.PubMed

21.

Knobloch M, Mansuy IM. Dendritic spine loss and synaptic alterations in Alzheimer’s disease. Mol Neurobiol. 2008;37(1):73–82. doi:10.1007/s12035-008-8018-z.PubMedCrossRef

22.

Yankner BA, Lu T, Loerch P. The aging brain. Annu Rev Pathol. 2008;3:41–66. doi:10.1146/annurev.pathmechdis.2.010506.092044.PubMedCrossRef

23.

Pan CL, Peng CY, Chen CH, McIntire S. Genetic analysis of age-dependent defects of the Caenorhabditis elegans touch receptor neurons. Proc Natl Acad Sci U S A. 2011;108(22):9274–9. doi:10.1073/pnas.1011711108.PubMedPubMedCentralCrossRef

24.

Toth ML, Melentijevic I, Shah L, Bhatia A, Lu K, Talwar A, et al. Neurite sprouting and synapse deterioration in the aging Caenorhabditis elegans nervous system. J Neurosci. 2012;32(26):8778–90. doi:10.1523/JNEUROSCI.1494-11.2012.PubMedPubMedCentralCrossRef

25.

Apfeld J, Kenyon C. Regulation of lifespan by sensory perception in Caenorhabditis elegans. Nature. 1999;402(6763):804–9. doi:10.1038/45544.PubMedCrossRef

26.

Alcedo J, Kenyon C. Regulation of C. elegans longevity by specific gustatory and olfactory neurons. Neuron. 2004;41(1):45–55.PubMedCrossRef

27.

Wolkow CA, Kimura KD, Lee MS, Ruvkun G. Regulation of C. elegans life-span by insulinlike signaling in the nervous system. Science. 2000;290(5489):147–50.PubMedCrossRef

28.

Iser WB, Gami MS, Wolkow CA. Insulin signaling in Caenorhabditis elegans regulates both endocrine-like and cell-autonomous outputs. Dev Biol. 2007;303(2):434–47. doi:10.1016/j.ydbio.2006.04.467.PubMedPubMedCentralCrossRef

29.

Antebi A. Ageing: when less is more. Nature. 2007;447(7144):536–7. doi:10.1038/447536a.PubMedCrossRef

30.

Barkus RV, Klyachko O, Horiuchi D, Dickson BJ, Saxton WM. Identification of an axonal kinesin-3 motor for fast anterograde vesicle transport that facilitates retrograde transport of neuropeptides. Mol Biol Cell. 2008;19(1):274–83. doi:10.1091/mbc.E07-03-0261.PubMedPubMedCentralCrossRef

31.

Nonet ML, Staunton JE, Kilgard MP, Fergestad T, Hartwieg E, Horvitz HR, et al. Caenorhabditis elegans rab-3 mutant synapses exhibit impaired function and are partially depleted of vesicles. J Neurosci. 1997;17(21):8061–73.PubMed

32.

Neumann B, Hilliard MA. Loss of MEC-17 leads to microtubule instability and axonal degeneration. Cell Rep. 2014;6(1):93–103. doi:10.1016/j.celrep.2013.12.004.PubMedPubMedCentralCrossRef

33.

Albeg A, Smith CJ, Chatzigeorgiou M, Feitelson DG, Hall DH, Schafer WR, et al. C. elegans multi-dendritic sensory neurons: morphology and function. Mol Cell Neurosci. 2011;46(1):308–17. doi:10.1016/j.mcn.2010.10.001.PubMedPubMedCentralCrossRef

34.

Gioran A, Nicotera P, Bano D. Impaired mitochondrial respiration promotes dendritic branching via the AMPK signaling pathway. Cell Death Dis. 2014;5:e1175. doi:10.1038/cddis.2014.144.PubMedCrossRef

35.

Maniar TA, Kaplan M, Wang GJ, Shen K, Wei L, Shaw JE, et al. UNC-33 (CRMP) and ankyrin organize microtubules and localize kinesin to polarize axon-dendrite sorting. Nat Neurosci. 2012;15(1):48–56. doi:10.1038/nn.2970.PubMedCentralCrossRef

36.

Mahoney TR, Luo S, Nonet ML. Analysis of synaptic transmission in Caenorhabditis elegans using an aldicarb-sensitivity assay. Nat Protoc. 2006;1(4):1772–7. doi:10.1038/nprot.2006.281.PubMedCrossRef

37.

Klassen MP, Wu YE, Maeder CI, Nakae I, Cueva JG, Lehrman EK, et al. An Arf-like small G protein, ARL-8, promotes the axonal transport of presynaptic cargoes by suppressing vesicle aggregation. Neuron. 2010;66(5):710–23. doi:10.1016/j.neuron.2010.04.033.PubMedPubMedCentralCrossRef

38.

Spires-Jones TL, de Calignon A, Meyer-Luehmann M, Bacskai BJ, Hyman BT. Monitoring protein aggregation and toxicity in Alzheimer’s disease mouse models using in vivo imaging. Methods. 2011;53(3):201–7. doi:10.1016/j.ymeth.2010.12.009.PubMedPubMedCentralCrossRef

39.

Caughey B, Lansbury PT. Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders. Annu Rev Neurosci. 2003;26:267–98. doi:10.1146/annurev.neuro.26.010302.081142.PubMedCrossRef

40.

Uversky VN. Targeting intrinsically disordered proteins in neurodegenerative and protein dysfunction diseases: another illustration of the D(2) concept. Expert Rev Proteomics. 2010;7(4):543–64. doi:10.1586/epr.10.36.PubMedPubMedCentralCrossRef

41.

Kraemer BC, Zhang B, Leverenz JB, Thomas JH, Trojanowski JQ, Schellenberg GD. Neurodegeneration and defective neurotransmission in a Caenorhabditis elegans model of tauopathy. Proc Natl Acad Sci U S A. 2003;100(17):9980–5. doi:10.1073/pnas.1533448100.PubMedPubMedCentralCrossRef

42.

von Bergen M, Friedhoff P, Biernat J, Heberle J, Mandelkow EM, Mandelkow E. Assembly of tau protein into Alzheimer paired helical filaments depends on a local sequence motif ((306)VQIVYK(311)) forming beta structure. Proc Natl Acad Sci U S A. 2000;97(10):5129–34.CrossRef

43.

Eckermann K, Mocanu MM, Khlistunova I, Biernat J, Nissen A, Hofmann A, et al. The beta-propensity of Tau determines aggregation and synaptic loss in inducible mouse models of tauopathy. J Biol Chem. 2007;282(43):31755–65. doi:10.1074/jbc.M705282200.PubMedCrossRef

44.

Jicha GA, Berenfeld B, Davies P. Sequence requirements for formation of conformational variants of tau similar to those found in Alzheimer’s disease. J Neurosci Res. 1999;55(6):713–23. doi:10.1002/(SICI)1097-4547(19990315)55:6<713::AID-JNR6>3.0.CO;2-G.PubMedCrossRef

45.

Butner KA, Kirschner MW. Tau protein binds to microtubules through a flexible array of distributed weak sites. J Cell Biol. 1991;115(3):717–30.PubMedCrossRef

46.

Goedert M, Wischik CM, Crowther RA, Walker JE, Klug A. Cloning and sequencing of the cDNA encoding a core protein of the paired helical filament of Alzheimer disease: identification as the microtubule-associated protein tau. Proc Natl Acad Sci U S A. 1988;85(11):4051–5.PubMedPubMedCentralCrossRef

47.

Magnani E, Fan J, Gasparini L, Golding M, Williams M, Schiavo G, et al. Interaction of tau protein with the dynactin complex. EMBO J. 2007;26(21):4546–54. doi:10.1038/sj.emboj.7601878.PubMedPubMedCentralCrossRef

48.

Ittner LM, Ke YD, Delerue F, Bi M, Gladbach A, van Eersel J, et al. Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer’s disease mouse models. Cell. 2010;142(3):387–97. doi:10.1016/j.cell.2010.06.036.PubMedCrossRef

49.

Williamson R, Scales T, Clark BR, Gibb G, Reynolds CH, Kellie S, et al. Rapid tyrosine phosphorylation of neuronal proteins including tau and focal adhesion kinase in response to amyloid-beta peptide exposure: involvement of Src family protein kinases. J Neurosci. 2002;22(1):10–20.PubMed

50.

Jeganathan S, Hascher A, Chinnathambi S, Biernat J, Mandelkow EM, Mandelkow E. Proline-directed pseudo-phosphorylation at AT8 and PHF1 epitopes induces a compaction of the paperclip folding of Tau and generates a pathological (MC-1) conformation. J Biol Chem. 2008;283(46):32066–76. doi:10.1074/jbc.M805300200.PubMedCrossRef

51.

Lee SE, Tartaglia MC, Yener G, Genc S, Seeley WW, Sanchez-Juan P, et al. Neurodegenerative disease phenotypes in carriers of MAPT p.A152T, a risk factor for frontotemporal dementia spectrum disorders and Alzheimer disease. Alzheimer Dis Assoc Disord. 2013;27(4):302–9. doi:10.1097/WAD.0b013e31828cc357.PubMedCrossRef

52.

Gauthier-Kemper A, Weissmann C, Golovyashkina N, Sebo-Lemke Z, Drewes G, Gerke V, et al. The frontotemporal dementia mutation R406W blocks tau’s interaction with the membrane in an annexin A2-dependent manner. J Cell Biol. 2011;192(4):647–61. doi:10.1083/jcb.201007161.PubMedPubMedCentralCrossRef

53.

Reynolds CH, Garwood CJ, Wray S, Price C, Kellie S, Perera T, et al. Phosphorylation regulates tau interactions with Src homology 3 domains of phosphatidylinositol 3-kinase, phospholipase Cgamma1, Grb2, and Src family kinases. J Biol Chem. 2008;283(26):18177–86. doi:10.1074/jbc.M709715200.PubMedCrossRef

54.

Roberson ED, Halabisky B, Yoo JW, Yao J, Chin J, Yan F, et al. Amyloid-beta/Fyn-induced synaptic, network, and cognitive impairments depend on tau levels in multiple mouse models of Alzheimer’s disease. J Neurosci. 2011;31(2):700–11. doi:10.1523/JNEUROSCI.4152-10.2011.PubMedPubMedCentralCrossRef

55.

Chevalier-Larsen E, Holzbaur EL. Axonal transport and neurodegenerative disease. Biochim Biophys Acta. 2006;1762(11-12):1094–108. doi:10.1016/j.bbadis.2006.04.002.PubMedCrossRef

56.

Tank EM, Rodgers KE, Kenyon C. Spontaneous age-related neurite branching in Caenorhabditis elegans. J Neurosci. 2011;31(25):9279–88. doi:10.1523/JNEUROSCI.6606-10.2011.PubMedPubMedCentralCrossRef

57.

Hirokawa N, Noda Y, Tanaka Y, Niwa S. Kinesin superfamily motor proteins and intracellular transport. Nat Rev Mol Cell Biol. 2009;10(10):682–96. doi:10.1038/nrm2774.PubMedCrossRef

58.

Kumar J, Choudhary BC, Metpally R, Zheng Q, Nonet ML, Ramanathan S, et al. The Caenorhabditis elegans Kinesin-3 motor UNC-104/KIF1A is degraded upon loss of specific binding to cargo. PLoS Genet. 2010;6(11):e1001200. doi:10.1371/journal.pgen.1001200.PubMedPubMedCentralCrossRef

59.

Arimoto M, Koushika SP, Choudhary BC, Li C, Matsumoto K, Hisamoto N. The Caenorhabditis elegans JIP3 protein UNC-16 functions as an adaptor to link kinesin-1 with cytoplasmic dynein. J Neurosci. 2011;31(6):2216–24. doi:10.1523/JNEUROSCI.2653-10.2011.PubMedCrossRef

60.

Koushika SP, Schaefer AM, Vincent R, Willis JH, Bowerman B, Nonet ML. Mutations in Caenorhabditis elegans cytoplasmic dynein components reveal specificity of neuronal retrograde cargo. J Neurosci. 2004;24(16):3907–16. doi:10.1523/JNEUROSCI.5039-03.2004.PubMedCrossRef

61.

Henriquez JP, Cross D, Vial C, Maccioni RB. Subpopulations of tau interact with microtubules and actin filaments in various cell types. Cell Biochem Funct. 1995;13(4):239–50. doi:10.1002/cbf.290130404.PubMedCrossRef

62.

Fulga TA, Elson-Schwab I, Khurana V, Steinhilb ML, Spires TL, Hyman BT, et al. Abnormal bundling and accumulation of F-actin mediates tau-induced neuronal degeneration in vivo. Nat Cell Biol. 2007;9(2):139–48. doi:10.1038/ncb1528.PubMedCrossRef

63.

Brunden KR, Trojanowski JQ, Lee VM. Evidence that non-fibrillar tau causes pathology linked to neurodegeneration and behavioral impairments. J Alzheimers Dis. 2008;14(4):393–9.PubMedPubMedCentral

64.

Marx J. Alzheimer’s disease. A new take on tau. Science. 2007;316(5830):1416–7. doi:10.1126/science.316.5830.1416.PubMedCrossRef

65.

Lasagna-Reeves CA, Castillo-Carranza DL, Sengupta U, Clos AL, Jackson GR, Kayed R. Tau oligomers impair memory and induce synaptic and mitochondrial dysfunction in wild-type mice. Mol Neurodegener. 2011;6:39. doi:10.1186/1750-1326-6-39.PubMedPubMedCentralCrossRef

66.

Haass C, Selkoe DJ. Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer’s amyloid beta-peptide. Nat Rev Mol Cell Biol. 2007;8(2):101–12. doi:10.1038/nrm2101.PubMedCrossRef

67.

Glabe CG. Common mechanisms of amyloid oligomer pathogenesis in degenerative disease. Neurobiol Aging. 2006;27(4):570–5. doi:10.1016/j.neurobiolaging.2005.04.017.PubMedCrossRef

68.

Caughey B, Baron GS, Chesebro B, Jeffrey M. Getting a grip on prions: oligomers, amyloids, and pathological membrane interactions. Annu Rev Biochem. 2009;78:177–204. doi:10.1146/annurev.biochem.78.082907.145410.PubMedPubMedCentralCrossRef

69.

Walther DM, Kasturi P, Zheng M, Pinkert S, Vecchi G, Ciryam P, et al. Widespread proteome remodeling and aggregation in aging C. elegans. Cell. 2015;161(4):919–32. doi:10.1016/j.cell.2015.03.032.PubMedCrossRef

70.

Olzscha H, Schermann SM, Woerner AC, Pinkert S, Hecht MH, Tartaglia GG, et al. Amyloid-like aggregates sequester numerous metastable proteins with essential cellular functions. Cell. 2011;144(1):67–78. doi:10.1016/j.cell.2010.11.050.PubMedCrossRef

71.

Kenyon C, Chang J, Gensch E, Rudner A, Tabtiang R. A C. elegans mutant that lives twice as long as wild type. Nature. 1993;366(6454):461–4. doi:10.1038/366461a0.PubMedCrossRef

72.

Preuss U, Biernat J, Mandelkow EM, Mandelkow E. The ‘jaws’ model of tau-microtubule interaction examined in CHO cells. J Cell Sci. 1997;110(Pt 6):789–800.PubMed

73.

von Bergen M, Barghorn S, Li L, Marx A, Biernat J, Mandelkow EM, et al. Mutations of tau protein in frontotemporal dementia promote aggregation of paired helical filaments by enhancing local beta-structure. J Biol Chem. 2001;276(51):48165–74. doi:10.1074/jbc.M105196200.

74.

Kage-Nakadai E, Kobuna H, Funatsu O, Otori M, Gengyo-Ando K, Yoshina S, et al. Single/low-copy integration of transgenes in Caenorhabditis elegans using an ultraviolet trimethylpsoralen method. BMC Biotechnol. 2012;12:1. doi:10.1186/1472-6750-12-1.PubMedPubMedCentralCrossRef

75.

Brenner S. The genetics of Caenorhabditis elegans. Genetics. 1974;77(1):71–94.PubMedPubMedCentral

76.

Gao S, Zhen M. Action potentials drive body wall muscle contractions in Caenorhabditis elegans. Proc Natl Acad Sci U S A. 2011;108(6):2557–62. doi:10.1073/pnas.1012346108.PubMedPubMedCentralCrossRef

77.

Jicha GA, Bowser R, Kazam IG, Davies P. Alz-50 and MC-1, a new monoclonal antibody raised to paired helical filaments, recognize conformational epitopes on recombinant tau. J Neurosci Res. 1997;48(2):128–32. doi:10.1002/(SICI)1097-4547(19970415)48:2<128::AID-JNR5>3.0.CO;2-E.PubMedCrossRef

78.

Gottschalk A, Almedom RB, Schedletzky T, Anderson SD, Yates 3rd JR, Schafer WR. Identification and characterization of novel nicotinic receptor-associated proteins in Caenorhabditis elegans. EMBO J. 2005;24(14):2566–78. doi:10.1038/sj.emboj.7600741.PubMedPubMedCentralCrossRef

79.

Tepper K, Biernat J, Kumar S, Wegmann S, Timm T, Hubschmann S, et al. Oligomer formation of tau protein hyperphosphorylated in cells. J Biol Chem. 2014;289(49):34389–407. doi:10.1074/jbc.M114.611368.PubMedPubMedCentralCrossRef

Title: Tau mutant A152T, a risk factor for FTD/PSP, induces neuronal dysfunction and reduced lifespan independently of aggregation in a C. elegans Tauopathy model
Authors: Ghulam Jeelani Pir
Bikash Choudhary
Eckhard Mandelkow
Eva-Maria Mandelkow
Publication date: 01-12-2016
Publisher: BioMed Central
Published in: Molecular Neurodegeneration / Issue 1/2016
Electronic ISSN: 1750-1326
DOI: https://doi.org/10.1186/s13024-016-0096-1

At a glance: The STEP trials

Springer Medicine

Tau mutant A152T, a risk factor for FTD/PSP, induces neuronal dysfunction and reduced lifespan independently of aggregation in a C. elegans Tauopathy model

Abstract

Background

Results

Conclusion

At a glance: The STEP trials

Springer Medicine

Abstract

Background

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2016

Enrichment of extracellular vesicles from tissues of the central nervous system by PROSPR

Resequencing analysis of five Mendelian genes and the top genes from genome-wide association studies in Parkinson’s Disease

Erratum to: A multifunctional therapeutic approach to disease modification in multiple familial mouse models and a novel sporadic model of Alzheimer’s disease

Transmission of α-synucleinopathy from olfactory structures deep into the temporal lobe

Early-life stress leads to impaired spatial learning and memory in middle-aged ApoE4-TR mice

Seizure protein 6 and its homolog seizure 6-like protein are physiological substrates of BACE1 in neurons